A splice variant of the human CCA-adding enzyme with modified activity

Area of Science:

• Molecular Biology
• Enzymology
• Genetics

Background:

• The human CCA-adding enzyme (tRNA nucleotidyltransferase) is crucial for protein biosynthesis.
• This enzyme adds the CCA terminus to tRNA precursors, essential for aminoacylation.
• Previously, only one form of this enzyme was known in humans.

Purpose of the Study:

• To identify and characterize a novel splice variant of the human CCA-adding enzyme.
• To investigate the sequence, activity, and potential in vivo relevance of this splice variant.

Main Methods:

• In silico analysis of cDNA databases to identify the splice variant.
• Recombinant protein expression and in vitro enzymatic activity assays.
• Comparison of the variant's activity with the full-length enzyme.

Main Results:

• A splice variant of the human CCA-adding enzyme was identified in public cDNA databases.
• In silico analysis revealed conserved alternative splice donor sites across species, suggesting in vivo usage.
• The recombinantly expressed splice variant demonstrated in vitro activity, adding CC to tRNA 3' ends.

Conclusions:

• The identified splice variant of the human CCA-adding enzyme is enzymatically active in vitro.
• Findings suggest the splice variant is expressed in cells, despite its distinct substrate acceptance compared to the full-length enzyme.
• The precise in vivo function of this splice variant remains to be elucidated.